期刊文献+

生长抑素受体在胆囊癌组织的表达及临床意义 被引量:2

Expression of Somatostatin Receptors in Gallbladder Cancer and its Significance
原文传递
导出
摘要 目的探讨生长抑素受体亚型蛋白在胆囊癌组织中的表达、发生发展中的作用及其相关性。方法对病理确诊的29例胆囊癌组织标本采用免疫组化法检测生长抑素受体亚型的表达。分析生长抑素受体亚型的表达与淋巴结转移、分化程度及预后的关系。结果 SSTR 5种亚型在胆囊癌组织均有表达,SSTR表达的优势是SSTR3;SSTR3在中高分化胆囊癌中的表达明显高于低分化胆囊癌(P<0.05);SSTR4在有淋巴结转移的胆囊癌的表达低于无淋巴结转移者(P<0.05)。经统计学分析,5种SSTR亚型表达情况均与患者年龄、肿瘤组织学类型、浸润深度、肝脏转移无明显相关性。结论胆囊癌组织及正常胆囊黏膜均表达5种SSTR亚型,优势表达是SSTR3;SSTR3及SSTR4的表达胆囊癌的恶性程度有关,提示这两种SSTR亚型表达可能在胆囊癌发展过程中发挥重要作用。 Objective To study the role of somatostatin receptor(SSTR) subtypes 1 - 5 in the process of genesis development of gallbladder cancer and their relationship. Methods Immunohistochemical staining was used to examine the expressions of SSTR1 - 5 in 29 cases of gallbladder cancer specimens. Results SSTR 5 subtypes in gallbladder cancer tissues were expressed, and the advantages expression was the SSTR3. The expression of SSTR3 in well-differentiated gallbladder carcinoma was signifi- cantly higher than poorly differentiated gallbladder carcinoma ( P 〈 0.05 ) ;The expression of SSTR4 with lymph node metastasis of gallbladder cancer was lower than that without lymph node metastasis( P 〈 0.05 ). The expression of 5 SSTR subtype were not as- sociated with patient age, tumor histological type, depth of invasion and liver metastasis. Conclusion Gallbladder cancers and normal gallbladder mucosa all expressed SSTR 5 subtypes protein, and the advantage expression was SSTR3;SSTR3 and SSTR4 was correlated with malignant degree of gallbladder cancer and may play an important role in the progression of gallbladder canc- er
出处 《中华全科医学》 2013年第1期80-82,共3页 Chinese Journal of General Practice
基金 上海市嘉定区卫生局课题(2009121)
关键词 胆囊癌 生长抑素 生长抑素受体 免疫组化 Gallbladder cancer Somatostatin Somatostain receptor Immunohistochemistry
  • 相关文献

参考文献12

  • 1De Aretxabala X,Losada H,Mora J,et al. Neoadjuvant chemoradio- therapy in gallbladder cancer [ J ]. Rev Med Chil, 2004,132 ( 1 ) : 51 - 57.
  • 2侯洪志,刘志远,房克敬.原发性胆囊癌21例外科治疗临床分析[J].中华全科医学,2011,9(10):1559-1559. 被引量:3
  • 3Hall GH, Tumbull LW, Richmond I, et al. Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumors [ J ]. Br J Cancer, 2002,87 ( 1 ) : 86 -88.
  • 4秦一雨,李济宇,李松岗,全志伟.生长抑素对胆囊癌细胞株的致凋亡研究[J].中华肝胆外科杂志,2009,15(1):45-48. 被引量:5
  • 5全志伟,李济宇,张强,刘建文.生长抑素对胆囊癌细胞生长周期的影响[J].外科理论与实践,2003,8(1):56-58. 被引量:10
  • 6Gisela O, Cecile V, Heike K, et al. Regulation and function of soma- tostatin receptors [ J ]. J Neurochem,2004,89 ( 5 ) : 1057-1091.
  • 7Blaker M, Schmitz M, Gocht A, et al. Diferential expression of soma- tostatin receptor subtypes in hepatocellular carcinomas [ J ]. J Hepatol, 2004,41(1) :112-118.
  • 8Parry JJ, Chen R, Andrews R, et al. Identification of Critical Residues Involved in Ligand Binding and G Protein Signaling in Human Soma- tostatin Receptor Subtype 2 [ J ]. Endocrinology, 2012,153 ( 6 ) : 2747- 2755.
  • 9Pisarek H, Kunert-Radek J, Radek M, et al. Expression of somatostatin receptor subtypes in primary and recurrent gonadotropinomas:are som- atostatin receptors involved in pituitary adenoma recurrence? [ J ]. Neuro Endocrinol Lett,2011,32 (1) :96-101.
  • 10Lamberts SW, van der Lely A J, Holland LJ. New somatostatin ana- logs:will they fulfil old promises? [ J ]. Eur J Endocrinol,2002,146 ( 5 ) :701-705.

二级参考文献29

  • 1陈定伟,洪德飞,牟一平.腹腔镜手术中发现的胆囊癌21例报告[J].中华普通外科杂志,2005,20(2):85-86. 被引量:1
  • 2张圣道,韩天权.采用有效措施,努力降低意外胆囊癌的发生[J].外科理论与实践,2005,10(4):381-381. 被引量:2
  • 3乌新林,王占民,马道新,杨凤辉,孙建芝.外源野生型p53基因对人胆囊癌GBC-SD细胞生长的作用[J].中华实验外科杂志,2005,22(12):1477-1479. 被引量:4
  • 4禄韶英,石景森,王燕,孙学军,王泽忠.双期螺旋CT判定胆囊癌可切除性的意义[J].中华肝胆外科杂志,2006,12(4):278-279. 被引量:10
  • 5Dc Aretxabala X, Losada tI, MoraJ, et al. Neoadjuvant chemoradiotherapy in gallbladder cancer. Rev Med Chil, 2004, 132: 51-57.
  • 6Hejna M, Zielinski CC. Nonsurgical management of gallbladder cancer by cytotoxic treatment and radiotherapy. Expert Rev Anticancer Ther, 2001,1:291-300.
  • 7Li JY, Quan ZW, Zhang Q, et al. The synergistic inhibitory effect of somatostatin--doxorubicin co-treatment on gallbladder carcinoma. BMC Cancer, 2007,7:125.
  • 8Reubi JC. Krenning E, Lamberts SW, et al. In vitro detection of somatostalin receptors in human tumors. Digestion, 1993, 19:76-83.
  • 9Candi E, Melino G, De Lauranzi V, et al. Tamoxifen and so malostatin affect tumors by inducing apoptosis. Cancer Lett, 1995, 96:141-115.
  • 10Cbeung NW, Boyages SC. Somatostatin-14 and its analog oct reotide exert a cyiostatic effect on GH3 rat pituitary tumor cell prolifcration via a transient G0/G1 cell cycle block. Endocrinology.1995, 136: :4174-4181.

共引文献14

同被引文献22

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部